Form 4: National Healthcare Corp Director Emil E. Hassan Exercises Stock Options
SEC Form 4 Filing
Director Emil E. Hassan exercised options to purchase 5,500 shares of National Healthcare Corp (NHC) common stock at a price of $64.64 on April 25, 2025.
Summary
- On April 25, 2025, Emil E. Hassan, a director of National Healthcare Corp (NHC), exercised stock options to acquire 5,500 shares of common stock.
- The exercise price for these options was $64.64 per share.
- Following the transaction, Hassan directly owns 78,595 shares of NHC common stock.
- The exercised options were granted on May 7, 2020, under the 2020 Omnibus Equity Incentive Plan.
- Hassan also holds options to purchase additional shares of common stock under grants from 2021, 2022, 2023 and 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction (option exercise) by a director. It doesn't inherently indicate positive or negative prospects for the company, but rather reflects a planned part of the director's compensation.
Positives
- The exercise of options by a director could be interpreted as a positive signal, indicating confidence in the company's future performance.
Industry Context
Option exercises by company directors are a common occurrence and are generally viewed in the context of the director's overall compensation package and their alignment with shareholder interests. It's typical for directors to receive stock options as part of their compensation, incentivizing them to increase shareholder value.
Comparison to Industry Standards
- Comparing Emil Hassan's option exercises to those of directors at similar healthcare companies like Brookdale Senior Living or Life Care Centers of America would provide a benchmark.
- Analyzing the percentage of equity held by Hassan relative to other NHC directors and industry peers can offer insights into his level of investment and alignment with shareholder interests.
- Reviewing the vesting schedules and exercise prices of Hassan's options against industry norms can determine if his compensation is standard or exceptional.
Stakeholder Impact
- The exercise of stock options has a minimal direct impact on stakeholders.
- It slightly increases the number of outstanding shares, but the effect is negligible given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 05/07/2020 | Date of grant for the exercised stock options under the 2020 Omnibus Equity Incentive Plan. |
| 05/07/2021 | Exercisable date for 2020 Grant options. |
| 05/06/2022 | Exercisable date for 2021 Grant options. |
| 05/05/2023 | Exercisable date for 2022 Grant options. |
| 05/04/2024 | Exercisable date for 2023 Grant options. |
| 04/25/2025 | Date of the stock option exercise by Emil E. Hassan. |
| 05/06/2025 | Expiration date for 2021 Grant options. |
| 05/09/2025 | Exercisable date for 2024 Grant options. |
| 05/04/2027 | Expiration date for 2022 Grant options. |
| 05/03/2028 | Expiration date for 2023 Grant options. |
| 05/08/2029 | Expiration date for 2024 Grant options. |
| 04/28/2025 | Date of signature for the Form 4 filing. |
Keywords
stock options, director, NHC, National Healthcare Corp, Form 4, equity incentive plan, beneficial ownership, Emil E. Hassan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.